| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/22/2011 | CN102100689A Application of flavonone compound in preparation of anti-tumor medicament |
| 06/22/2011 | CN102100688A Application of zedoary cyclic diolefine in preparation of medicine for resisting neoplasm metastasis |
| 06/22/2011 | CN102100670A Poly(lactic-co-glycolic acid) nanoparticle, preparation method and application thereof |
| 06/22/2011 | CN102100669A Immunity liposome, and preparation method and application thereof |
| 06/22/2011 | CN102100667A Method for stabilizing tegafur in aqueous solution |
| 06/22/2011 | CN102100265A Ganoderma and mushroom tea |
| 06/22/2011 | CN101716156B Ubenimex dispersive tablet composition |
| 06/22/2011 | CN101690794B Antitumor medicament, preparation method and quality control method |
| 06/22/2011 | CN101669972B Preparation method of capsules for treating breast cancer |
| 06/22/2011 | CN101633645B N3 alkylated benzimidazole derivatives as mek inhibitors |
| 06/22/2011 | CN101623320B Externally-applied purely-natural traditional Chinese medicine preparation for treating ulceratiue stomatitis and preparation method thereof |
| 06/22/2011 | CN101590209B Medicament for treating tumors and preparation method thereof |
| 06/22/2011 | CN101575602B siRNA sequence for inhibiting human BFGF gene expression amplification and expression carrier and application thereof |
| 06/22/2011 | CN101575333B Quinazoline derivatives and medical application thereof |
| 06/22/2011 | CN101574340B Rhododendrin and application of rhododendrin and salts thereof in preparing anti-tumor medicament |
| 06/22/2011 | CN101570512B Curcumin substituted pyrazole derivatives, and preparation method and uses thereof |
| 06/22/2011 | CN101560206B Intermediate of pemetrexed disodium, preparation method thereof and method for preparing pemetrexed disodium thereby |
| 06/22/2011 | CN101538293B Method for preparing secoisolariciresinol diglucoside and ferulic acid glucoside or ferulic acid glucoside ethyl ester |
| 06/22/2011 | CN101537101B Drug used for curing liver, limb muscles and pelvic blood vessel tumors and complicating diseases thereof, varicosity of leg and ulcer with hemorrhage and a preparation method thereof |
| 06/22/2011 | CN101530548B Composition with multiple health-care functions and preparation method thereof |
| 06/22/2011 | CN101519646B CIK cell, as well as preparation method and cell preparation thereof |
| 06/22/2011 | CN101502611B Medicament for treating cancer and preparation method thereof |
| 06/22/2011 | CN101492410B Indirubin compounds for antineoplastic medicament |
| 06/22/2011 | CN101475571B Beta-carbolines cell cycle protein related kinase 2 inhibitor and use thereof |
| 06/22/2011 | CN101440111B Anti-tumor compound and preparation thereof |
| 06/22/2011 | CN101434650B Bursa pentapeptide, deriving peptide thereof and use thereof |
| 06/22/2011 | CN101401896B Extracting method of active principle of sarsaparilla |
| 06/22/2011 | CN101396378B Nano gene peptides products and preparation method and use thereof |
| 06/22/2011 | CN101371890B Medicaments composite for treating gland hyperplasia and breast cancer and preparation method thereof |
| 06/22/2011 | CN101361749B Steroid saponin compound and use thereof in preparing anti-tumor medicine |
| 06/22/2011 | CN101327315B Use of maltose binding protein as immunopotentiator |
| 06/22/2011 | CN101270168B Hyaluronic acid stem grafting polyethylene imine copolymer, preparing method and application as genophore |
| 06/22/2011 | CN101213164B Aryl dihydro-naphthalene compounds, their preparation and their use as Akt inhibitor for the prevention and treatment of cancer |
| 06/22/2011 | CN101173008B Double-function amalgamation protein, preparation method and application thereof |
| 06/22/2011 | CN101167787B Albizzia plant extraction composition for inhibiting angiogenesis and preparation and application thereof |
| 06/22/2011 | CN101144081B Nucleic acid molecule TRAIL and application in preparation of anti-tumour pharmaceutical |
| 06/22/2011 | CN101062374B Method for preparing Chinese traditional combination capsule for treating cancer and the product thereof |
| 06/22/2011 | CN101062045B Use of triterpene saponin compounds in preparing tumor medicine |
| 06/22/2011 | CN101044247B Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 06/22/2011 | CN101002825B Method for preparing Duzhong soft capsule rich in alpha-linolenic acid and effective component of bark of eucommia |
| 06/22/2011 | CN101001857B 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 06/21/2011 | US7964734 Raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these |
| 06/21/2011 | US7964724 Chiral cis-imidazolines |
| 06/21/2011 | US7964712 Chimeric nucleic acids encoding polypeptides comprising TNF alpha, CD70 and FAS ligand domains |
| 06/21/2011 | US7964711 Compositions comprising polynucleotides encoding TACI-immunoglobulin fusion proteins and methods for producing the same |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964400 Immune potentiating compositions of cancer cells |
| 06/21/2011 | US7964374 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/21/2011 | US7964187 Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus |
| 06/21/2011 | US7964186 modified adenovirus containing mutation in or lacks the virus associated RNA gene, modified HSV, vaccinia virus and parapoxvirus; Ras-activated pathway; neoplasm; immunosuppressant |
| 06/21/2011 | CA2632283C Polymorphs of a c-met/hgfr inhibitor |
| 06/21/2011 | CA2563000C Indene derivatives and process for the preparation thereof |
| 06/21/2011 | CA2495386C Protein kinase inhibitors and uses thereof |
| 06/21/2011 | CA2486336C Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
| 06/21/2011 | CA2481602C Pharmaceutical composition comprising arsenite for the treatment of malignancy |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
| 06/21/2011 | CA2472188C Polymeric gel system for the controlled delivery of codrugs |
| 06/21/2011 | CA2469801C Thiadiazoline derivative |
| 06/21/2011 | CA2462537C Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 06/21/2011 | CA2446429C Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies |
| 06/21/2011 | CA2439857C Caloporoside derivatives, process for their preparation and their use |
| 06/21/2011 | CA2407556C Gene detection assay for improving the likelihood of an effective response to an erbb antagonist cancer therapy |
| 06/21/2011 | CA2405290C Vaccine against cancerous diseases |
| 06/21/2011 | CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon |
| 06/21/2011 | CA2370775C Use of a serenoa repens extract for the production of a medicament to treat prostate cancer |
| 06/21/2011 | CA2370143C Esters of l-carnitine or alkanoyl l-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/21/2011 | CA2345079C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 06/21/2011 | CA2323071C Molecules that home to various selected organs or tissues |
| 06/21/2011 | CA2288222C Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
| 06/18/2011 | CA2725650A1 Polyphenol compounds for inhibiting proteasome and uses thereof |
| 06/16/2011 | WO2011072292A2 Phase changing formulations of rna and rna derivatives |
| 06/16/2011 | WO2011072290A2 Targeted dendrimer-drug conjugates |
| 06/16/2011 | WO2011072275A2 Agents and methods for treating ischemic and other diseases |
| 06/16/2011 | WO2011072218A2 Stable formulations for lyophilizing therapeutic particles |
| 06/16/2011 | WO2011072205A2 Genetic markers indicative of a cancer patient response to trastuzumab (herceptin) |
| 06/16/2011 | WO2011072181A2 Method of treating pancreatic cancer |
| 06/16/2011 | WO2011072174A1 Therapeutically active compounds for use in the treatment of cancer characterized as having an idh mutation |
| 06/16/2011 | WO2011072138A2 Therapeutic use of protein-polymer conjugates |
| 06/16/2011 | WO2011071981A2 Anti-cytomegalovirus activity of artemisinin-derived dimers |
| 06/16/2011 | WO2011071970A2 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt) |
| 06/16/2011 | WO2011071968A2 Nanoparticle carrier systems based on human serum albumin for photodynamic therapy |
| 06/16/2011 | WO2011071916A2 Sr-bi as a predictor of human female infertility and responsiveness to treatment |
| 06/16/2011 | WO2011071821A1 Crystalline forms of 3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea and salts thereof. |
| 06/16/2011 | WO2011071725A1 Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core |
| 06/16/2011 | WO2011071632A2 Modified insm1-promoter for neuroendocrine tumor therapy and diagnostics |
| 06/16/2011 | WO2011071577A1 Anti-vegf-c antibodies and methods using same |
| 06/16/2011 | WO2011071194A1 SOLID DISPERSIONS CONTAINING 20-O-β-D-GLUCOPYRANOSYL-20(S)-PROTOPANAXADIOL |
| 06/16/2011 | WO2011071099A1 Anticancer anti-mortalin peptide antibodies |
| 06/16/2011 | WO2011070974A1 Cell preparation for treating prostatic cancer comprising adipose tissue-derived mesenchymal stem cells |
| 06/16/2011 | WO2011070970A1 Overexpression inhibitor of thymic stromal lymphopoietin |
| 06/16/2011 | WO2011070358A2 Product and method |
| 06/16/2011 | WO2011070299A1 Tri-substituted 9h-beta-carboline (or 9h-pyrido[3,4-b]indole) derivatives, preparation of same and therapeutic use thereof |
| 06/16/2011 | WO2011070298A1 Di-substituted 9h-pyrido[3,4-b]indole derivatives, preparation of same and therapeutic use thereof |
| 06/16/2011 | WO2011070150A1 Novel targets for the treatment of proliferative diseases |
| 06/16/2011 | WO2011070088A1 Anti-c4.4a antibodies and uses thereof |
| 06/16/2011 | WO2011070030A1 Heterocyclic sulfonamide derivatives |